This project integrates multiple parameters into a risk-based model to improve the accuracy of early lung cancer detection and distinguish benign from malignant nodules.
Solutions de Diagnostic Biomark inc.
6 enregistrements totalisant 996,050.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $996,050 | 6 enregistrements |
Enregistrements
Development of a safe, effective and affordable drug biomarker test to assess and monitor response to cancer therapy.
Development of a non-invasive, highly sensitive and accurate molecular test for the early detection and screening of lung cancer
This feasibility project is aiming to develop a non-invasive blood test that can detect breast cancer at a very early stage, when treatment is most effective.
The project will fund the development of the firm's intellectual property capacity
Development of a cutting-edge technological platform for early cancer detection.